EFFECTS OF NIFEDIPINE ON HEPATIC DRUG OXIDATION

被引:5
作者
DICKINSON, TH [1 ]
EGAN, JM [1 ]
ABERNETHY, DR [1 ]
机构
[1] BROWN UNIV,ROGER WILLIAMS GEN HOSP,DEPT MED,DIV CLIN PHARMACOL,825 CHALKSTONE AVE,PROVIDENCE,RI 02908
关键词
D O I
10.1159/000138329
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:405 / 410
页数:6
相关论文
共 26 条
[1]  
ABERNETHY DR, IN PRESS J PHARM EXP
[2]  
ANDREASEN PB, 1974, CLIN PHARMACOL THER, V16, P1059
[3]   NIFEDIPINE THERAPY FOR CORONARY-ARTERY SPASM - EXPERIENCE IN 127 PATIENTS [J].
ANTMAN, E ;
MULLER, J ;
GOLDBERG, S ;
MACALPIN, R ;
RUBENFIRE, M ;
TABATZNIK, B ;
LIANG, CS ;
HEUPLER, F ;
ACHUFF, S ;
REICHEK, N ;
GELTMAN, E ;
KERIN, NZ ;
NEFF, RK ;
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (23) :1269-1273
[4]   CHANGES IN ANTIPYRINE AND INDOCYANINE GREEN KINETICS DURING NIFEDIPINE, VERAPAMIL, AND DILTIAZEM THERAPY [J].
BAUER, LA ;
STENWALL, M ;
HORN, JR ;
DAVIS, R ;
OPHEIM, K ;
GREENE, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) :239-242
[5]   INHIBITION OF ANTIPYRINE METABOLISM BY BETA-ADRENOCEPTOR ANTAGONISTS [J].
BAX, NDS ;
LENNARD, MS ;
TUCKER, GT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :779-784
[6]  
BOLGER GT, 1983, J PHARMACOL EXP THER, V225, P291
[7]   DILTIAZEM TREATMENT IMPAIRS HEPATIC DRUG OXIDATION - STUDIES OF ANTIPYRINE [J].
CARRUM, G ;
EGAN, JM ;
ABERNETHY, DR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) :140-143
[9]   ASSAY OF ANTIPYRINE AND ITS PRIMARY METABOLITES IN PLASMA, SALIVA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND SOME PRELIMINARY-RESULTS IN MAN [J].
DANHOF, M ;
GROOTVANDERVIS, ED ;
BREIMER, DD .
PHARMACOLOGY, 1979, 18 (04) :210-223
[10]   STUDIES OF THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN MAN - ORAL VERSUS IV ADMINISTRATION AND THE INFLUENCE OF URINARY COLLECTION TIME [J].
DANHOF, M ;
VANZUILEN, A ;
BOEIJINGA, JK ;
BREIMER, DD .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (05) :433-441